Your Messages Inbox
Your Article Summary
See Latest ArticlesAntigenics Presents Positive Oncophage Interim Survival Data at ASCO
Antigenics, 06/16/09
Antigenics Inc. announced results of an interim analysis from the company's ongoing global patient survival registry, which showed that patients with kidney cancer at intermediate risk of disease recurrence demonstrated an approximately 46 percent lower risk of death when treated with Oncophage cancer vaccine after surgery compared with observation.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6L
BioPharm, 12/09/09
Bivariate Random Effects Meta-Analysis of Diagnostic Studies Using Generalized Linear Mixed Models
Medical Decision Making, 12/09/09
The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/09/09
Article Search
Sponsor